Previous close | 30.88 |
Open | 31.31 |
Bid | 31.24 x 1100 |
Ask | 34.20 x 800 |
Day's range | 30.80 - 32.77 |
52-week range | 16.78 - 40.00 |
Volume | |
Avg. volume | 440,822 |
Market cap | 1.852B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
WILMINGTON, Del., May 31, 2023--Phreesia, Inc. (NYSE: PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2023.
WILMINGTON, Del., May 17, 2023--Phreesia has been selected by Modern Healthcare as one of the 2023 Best Places to Work in Healthcare.
WILMINGTON, Del., May 16, 2023--Phreesia is pleased to announce that Hilary Hatch, PhD, Phreesia’s Chief Clinical Officer, has been named as one of the 2023 PM360 ELITE 100 by healthcare-marketing trade publication, PM360.
WILMINGTON, Del., April 25, 2023--Phreesia, Inc. will release its fiscal first quarter 2024 financial results after the close of market trading on Wednesday, May 31, 2023.
CINCINNATI & WILMINGTON, Del., March 29, 2023--Unlimited Systems and Phreesia are offering a new integration for independent oncology practices and health systems.
WILMINGTON, Del., March 22, 2023--Phreesia, Inc. (NYSE: PHR), a leader in patient intake, outreach and activation, today announced the appointment of Balaji Gandhi as Phreesia’s Chief Financial Officer. Gandhi will succeed Randy Rasmussen, effective March 24, 2023. Rasmussen will serve as a Strategic Advisor to the Company for a period of time, to facilitate a smooth transition of his responsibilities.
WILMINGTON, Del., March 22, 2023--Phreesia, Inc. (NYSE: PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2023.
WILMINGTON, Del., March 20, 2023--Phreesia has been named as one of the 2023 Achievers 50 Most Engaged Workplaces®.
WILMINGTON, Del., March 17, 2023--Phreesia announces that MM+M has named Alexandra Beneville, Vice President, Life Sciences Content Strategy, to its Women to Watch class of 2023.
WILMINGTON, Del., March 15, 2023--Phreesia is proud to announce that Dan Nathan, the company’s Chief Technology Officer, has been named as one of the Top 25 Software CTOs of 2023.
WILMINGTON, Del., February 02, 2023--Phreesia announces release date for fiscal fourth quarter 2023 results.
WILMINGTON, Del., January 31, 2023--Phreesia announces inclusion in the 2023 Bloomberg Gender-Equality Index (GEI).
WILMINGTON, Del. & NEW YORK, January 26, 2023--Phreesia, a leader in patient intake, outreach and activation, along with the Ad Council, a nonprofit organization at the forefront of driving change through social impact marketing, have collaborated to bring three public health campaigns directly to patients and caregivers. Initial results show the campaigns are helping to raise awareness about critical health issues and encouraging important conversations between patients, caregivers and healthca
WILMINGTON, Del., January 20, 2023--Phreesia, a leader in patient intake, outreach and activation, is pleased to announce that for the second year in a row, the healthcare marketing industry trade publication Medical Marketing and Media (MM+M) has named Phreesia Life Sciences to its list of Best Places to Work 2022.
WILMINGTON, Del., December 08, 2022--Phreesia, Inc. (NYSE: PHR) ("Phreesia" or the "Company") announced financial results today for the third quarter ended October 31, 2022.
WILIMINGTON, Del., November 16, 2022--Phreesia is proud to announce that Sara DiNardo, the company’s Vice President of Client Solutions, has been named to The Software Report’s list of the Top 50 Women Leaders in SaaS of 2022.
RALEIGH, N.C., October 28, 2022--Phreesia, Inc. (NYSE: PHR) ("Phreesia") today announced that it will release its fiscal third quarter 2023 financial results after the close of market trading on Thursday, December 8, 2022. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal third quarter results s
WILMINGTON, Del., September 22, 2022--Phreesia, a leader in patient intake, outreach and activation, has named Alexandra Beneville as Vice President of Life Sciences Content Strategy. Beneville officially joined Phreesia on Aug. 1, 2022, from Phosphorus, a direct-to-consumer genomic testing company, where she had served as Vice President of Marketing since December 2021.
WILMINGTON, Del., September 16, 2022--Phreesia is proud to announce that Zeeshan Butt, PhD, a Director of Clinical Content, has been selected to serve a three-year term as a member of the National Quality Forum (NQF)’s Measure Applications Partnership (MAP) 2022-2023 Clinician Workgroup.
RALEIGH, N.C., September 07, 2022--Phreesia, Inc. (NYSE: PHR) ("Phreesia" or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2022.
RALEIGH, N.C., July 29, 2022--Phreesia, Inc. (NYSE: PHR) ("Phreesia") today announced that it will release its fiscal second quarter 2023 financial results after the close of market trading on Wednesday, September 7, 2022. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at ir.phreesia.com. Phreesia will then hold a conference call to discuss its fiscal second quarter results
RALEIGH, N.C., July 20, 2022--Phreesia is pleased to announce that it has been named to The Software Report’s list of "The Top 100 Software Companies of 2022." The annual award recognizes the best companies leading the software industry forward, considering criteria including product quality, organizational effectiveness and management caliber.
RALEIGH, N.C., June 22, 2022--Patients’ expectations of healthcare technology are changing to reflect the digital conveniences they are used to in other aspects of their lives, according to research in a newly published white paper from Phreesia. Based on the results of a survey of 4,136 patients, the paper sheds light on the consumer-centric trends reshaping healthcare delivery and shares best practices that healthcare organizations can employ to improve patients’ experience and better engage t
NEWBURY PARK, Calif. & RALEIGH, N.C., June 07, 2022--Compulink Healthcare Solutions, a leader in specialty-specific all-in-one EHR solutions; and Phreesia, a leader in patient intake, outreach and activation, are pleased to announce that they have partnered to offer a robust, bidirectional integration between their systems. This integration will help practices save time, increase patient collections, improve patient satisfaction, and keep their schedules full.